EoI for Development and Manufacture of Multiple Strengths of C-Mn3O4 NP Nanodrug Formulations and Matching Placebo for Clinical Trial Batches for Neonatal Hyperbilirubinemia and Associated Neurotoxicity or Bilirubin Encephalopathy (Last dt: Oct 21, '26)



